SEMLER SCIENTIFIC INC (SMLR) Stock Fundamental Analysis
USA - NASDAQ:SMLR - US81684M1045 - Common Stock
29.18 USD
-0.31 (-1.05%)
29.18 USD
0 (0%)
Overall SMLR gets a fundamental rating of 5 out of 10. We evaluated SMLR against 191 industry peers in the Health Care Equipment & Supplies industry. SMLR scores excellent on profitability, but there are concerns on its financial health. SMLR has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year SMLR was profitable.
SMLR had a positive operating cash flow in the past year.
SMLR had positive earnings in each of the past 5 years.
In the past 5 years SMLR always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of SMLR (7.09%) is better than 88.48% of its industry peers.
SMLR's Return On Equity of 9.66% is amongst the best of the industry. SMLR outperforms 83.77% of its industry peers.
SMLR's Return On Invested Capital of 0.92% is fine compared to the rest of the industry. SMLR outperforms 68.06% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SMLR is significantly above the industry average of 8.46%.
The last Return On Invested Capital (0.92%) for SMLR is well below the 3 year average (20.14%), which needs to be investigated, but indicates that SMLR had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.09% | ||
| ROE | 9.66% | ||
| ROIC | 0.92% |
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)20.14%
ROIC(5y)28.39%
1.3 Margins
With an excellent Profit Margin value of 86.20%, SMLR belongs to the best of the industry, outperforming 98.95% of the companies in the same industry.
SMLR's Profit Margin has improved in the last couple of years.
The Operating Margin of SMLR (12.16%) is better than 79.06% of its industry peers.
In the last couple of years the Operating Margin of SMLR has grown nicely.
Looking at the Gross Margin, with a value of 90.91%, SMLR belongs to the top of the industry, outperforming 98.43% of the companies in the same industry.
In the last couple of years the Gross Margin of SMLR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.16% | ||
| PM (TTM) | 86.2% | ||
| GM | 90.91% |
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
2. Health
2.1 Basic Checks
SMLR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
Compared to 1 year ago, SMLR has more shares outstanding
Compared to 5 years ago, SMLR has more shares outstanding
There is no outstanding debt for SMLR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
An Altman-Z score of 2.24 indicates that SMLR is not a great score, but indicates only limited risk for bankruptcy at the moment.
SMLR's Altman-Z score of 2.24 is fine compared to the rest of the industry. SMLR outperforms 64.92% of its industry peers.
The Debt to FCF ratio of SMLR is 7.90, which is on the high side as it means it would take SMLR, 7.90 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.90, SMLR is in the better half of the industry, outperforming 75.92% of the companies in the same industry.
SMLR has a Debt/Equity ratio of 0.25. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.25, SMLR is in line with its industry, outperforming 53.93% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 7.9 | ||
| Altman-Z | 2.24 |
ROIC/WACC0.11
WACC8.7%
2.3 Liquidity
A Current Ratio of 0.60 indicates that SMLR may have some problems paying its short term obligations.
SMLR's Current ratio of 0.60 is on the low side compared to the rest of the industry. SMLR is outperformed by 91.62% of its industry peers.
SMLR has a Quick Ratio of 0.60. This is a bad value and indicates that SMLR is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of SMLR (0.58) is worse than 90.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.58 |
3. Growth
3.1 Past
SMLR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 201.43%, which is quite impressive.
Measured over the past years, SMLR shows a very strong growth in Earnings Per Share. The EPS has been growing by 24.17% on average per year.
The Revenue for SMLR has decreased by -30.40% in the past year. This is quite bad
The Revenue has been growing by 11.43% on average over the past years. This is quite good.
EPS 1Y (TTM)201.43%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%687.5%
Revenue 1Y (TTM)-30.4%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-43.19%
3.2 Future
The Earnings Per Share is expected to decrease by -27.06% on average over the next years. This is quite bad
The Revenue is expected to decrease by -16.29% on average over the next years. This is quite bad
EPS Next Y-162.03%
EPS Next 2Y-42.88%
EPS Next 3Y-27.06%
EPS Next 5YN/A
Revenue Next Year-40.74%
Revenue Next 2Y-23.76%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 3.47, the valuation of SMLR can be described as very cheap.
SMLR's Price/Earnings ratio is rather cheap when compared to the industry. SMLR is cheaper than 98.43% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.41, SMLR is valued rather cheaply.
The Forward Price/Earnings Ratio is negative for SMLR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 3.47 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SMLR indicates a somewhat cheap valuation: SMLR is cheaper than 62.83% of the companies listed in the same industry.
79.06% of the companies in the same industry are more expensive than SMLR, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 35.46 | ||
| EV/EBITDA | 91.16 |
4.3 Compensation for Growth
The excellent profitability rating of SMLR may justify a higher PE ratio.
SMLR's earnings are expected to decrease with -27.06% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.14
EPS Next 2Y-42.88%
EPS Next 3Y-27.06%
5. Dividend
5.1 Amount
SMLR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
29.18
-0.31 (-1.05%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners61.19%
Inst Owner Change40.39%
Ins Owners5.29%
Ins Owner Change0.32%
Market Cap431.86M
Analysts82.22
Price Target87.04 (198.29%)
Short Float %19.22%
Short Ratio4.04
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-12.93%
PT rev (3m)20.19%
EPS NQ rev (1m)-5.26%
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.32%
EPS NY rev (3m)-291.76%
Revenue NQ rev (1m)1.05%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)1.14%
Revenue NY rev (3m)-41.37%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 3.47 | ||
| Fwd PE | N/A | ||
| P/S | 10.05 | ||
| P/FCF | 35.46 | ||
| P/OCF | 34.66 | ||
| P/B | 1.13 | ||
| P/tB | N/A | ||
| EV/EBITDA | 91.16 |
EPS(TTM)8.41
EY28.82%
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)0.82
FCFY2.82%
OCF(TTM)0.84
OCFY2.89%
SpS2.9
BVpS25.91
TBVpS-7.67
PEG (NY)N/A
PEG (5Y)0.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.09% | ||
| ROE | 9.66% | ||
| ROCE | 1.08% | ||
| ROIC | 0.92% | ||
| ROICexc | 0.95% | ||
| ROICexgc | N/A | ||
| OM | 12.16% | ||
| PM (TTM) | 86.2% | ||
| GM | 90.91% | ||
| FCFM | 28.34% |
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)20.14%
ROIC(5y)28.39%
ROICexc(3y)84.34%
ROICexc(5y)123.7%
ROICexgc(3y)231.99%
ROICexgc(5y)212.29%
ROCE(3y)23.58%
ROCE(5y)33.24%
ROICexcg growth 3Y32.01%
ROICexcg growth 5Y21.37%
ROICexc growth 3Y-65.32%
ROICexc growth 5Y-45.58%
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
F-Score3
Asset Turnover0.08
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 7.9 | ||
| Debt/EBITDA | 16.92 | ||
| Cap/Depr | 60.82% | ||
| Cap/Sales | 0.65% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 218.98% | ||
| Profit Quality | 32.88% | ||
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.58 | ||
| Altman-Z | 2.24 |
F-Score3
WACC8.7%
ROIC/WACC0.11
Cap/Depr(3y)171.05%
Cap/Depr(5y)155.18%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.73%
Profit Quality(3y)88.64%
Profit Quality(5y)91.36%
High Growth Momentum
Growth
EPS 1Y (TTM)201.43%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%687.5%
EPS Next Y-162.03%
EPS Next 2Y-42.88%
EPS Next 3Y-27.06%
EPS Next 5YN/A
Revenue 1Y (TTM)-30.4%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-43.19%
Revenue Next Year-40.74%
Revenue Next 2Y-23.76%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A
EBIT growth 1Y-75.28%
EBIT growth 3Y2.48%
EBIT growth 5Y14.34%
EBIT Next Year-327.64%
EBIT Next 3Y-39.26%
EBIT Next 5YN/A
FCF growth 1Y-37.74%
FCF growth 3Y16.95%
FCF growth 5Y17.17%
OCF growth 1Y-42.82%
OCF growth 3Y14.98%
OCF growth 5Y13.91%